Literature DB >> 18759680

Acellular dermal matrix compared with synthetic implant material for repair of ventral hernia in the setting of peri-operative Staphylococcus aureus implant contamination: a rabbit model.

Meghan L Milburn1, Luther H Holton, Thomas L Chung, Edward N Li, Grant V Bochicchio, Nelson H Goldberg, Ronald P Silverman.   

Abstract

BACKGROUND: Implant infection is a common clinical complication of abdominal hernia repair. Our objectives were to determine if acellular dermal matrix (ADM) grafts resisted Staphylococcus aureus infection better (as measured by ability to reduce or clear bacterial counts) than synthetic (polytetrafluoroethylene [PTFE]) mesh when used in abdominal wall reconstruction, and to determine whether vascularization of the implant occurred. We hypothesized that the ability of the ADM grafts to vascularize and allow cellular ingrowth would allow the immune system to clear the infection better in these animals.
METHODS: In New Zealand White rabbits (average weight, 3.0 kg), a full-thickness 3 x 3 cm(2) abdominal defect was created, then repaired with an interpositional implant (ADM, n = 62; PTFE, n = 57). Before skin closure, the epidermal surface of each implant was inoculated with 1 mL of S. aureus at various concentrations (10(4) colony-forming units [CFU]/mL, n = 82; 10(6) CFU/mL, n = 27; 10(9) CFU/mL, n = 10), and the rabbits were harvested at either day 7 or day 21.
RESULTS: At day 7, ADM grafts inoculated with 10(4) CFU had lower counts or no bacteria (p = 0.006), fewer adhesions (p = 0.005), and fewer abscesses (p = 0.008) than PTFE grafts. By day 21, more ADM (n = 12) than PTFE (n = 0) grafts were free of bacteria (p = 0.002). Fewer rabbits with ADM grafts formed abscesses (13 vs. 19; p = 0.03). When evaluating the 7- and 21-day 10(4) CFU groups combined, a total of 15 rabbits with ADM cleared the bacteria completely vs. none of those with PTFE grafts (p < 0.001). There was no significant difference in bacterial counts or wound complications at days 7 or 21 between PTFE and ADM implants when inoculated with 10(6) CFU. All rabbits inoculated with 10(9) CFU died of sepsis within 48 h. Herniation did not occur in any of the animals.
CONCLUSIONS: Our study demonstrates that ADM resists surgical site infection caused by S. aureus in an animal model without compromising the ventral hernia repair. This ability of ADM grafts to perform well in the setting of infection is most likely attributable to their capacity to vascularize and aid clearance of bacteria.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759680     DOI: 10.1089/sur.2007.044

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  25 in total

1.  Effect of enzymatic degradation on the mechanical properties of biological scaffold materials.

Authors:  Afua H Annor; Michael E Tang; Chi Lun Pui; Gregory C Ebersole; Margaret M Frisella; Brent D Matthews; Corey R Deeken
Journal:  Surg Endosc       Date:  2012-04-27       Impact factor: 4.584

Review 2.  Infected animal models for tissue engineering.

Authors:  Alexander M Tatara; Sarita R Shah; Carissa E Livingston; Antonios G Mikos
Journal:  Methods       Date:  2015-04-02       Impact factor: 3.608

3.  Response of endothelial cells to decellularized extracellular matrix deposited by bone marrow mesenchymal stem cells.

Authors:  Yue Xu; Mengdie Yan; Yihong Gong; Lei Chen; Feng Zhao; Zhaoqiang Zhang
Journal:  Int J Clin Exp Med       Date:  2014-12-15

4.  Bioprosthetic mesh in abdominal wall reconstruction.

Authors:  Donald P Baumann; Charles E Butler
Journal:  Semin Plast Surg       Date:  2012-02       Impact factor: 2.314

5.  Activation of human mononuclear cells by porcine biologic meshes in vitro.

Authors:  S B Orenstein; Y Qiao; U Klueh; D L Kreutzer; Y W Novitsky
Journal:  Hernia       Date:  2010-02-10       Impact factor: 4.739

6.  Early biocompatibility of crosslinked and non-crosslinked biologic meshes in a porcine model of ventral hernia repair.

Authors:  L Melman; E D Jenkins; N A Hamilton; L C Bender; M D Brodt; C R Deeken; S C Greco; M M Frisella; B D Matthews
Journal:  Hernia       Date:  2011-01-08       Impact factor: 4.739

7.  Bacterial clearance of biologic grafts used in hernia repair: an experimental study.

Authors:  K C Harth; A-M Broome; M R Jacobs; J A Blatnik; F Zeinali; S Bajaksouzian; M J Rosen
Journal:  Surg Endosc       Date:  2011-02-07       Impact factor: 4.584

8.  Human monocyte activation by biologic and biodegradable meshes in vitro.

Authors:  Sean B Orenstein; Yi Qiao; Manjot Kaur; Ulrike Klueh; Don L Kreutzer; Yuri W Novitsky
Journal:  Surg Endosc       Date:  2009-08-21       Impact factor: 4.584

Review 9.  Options for closure of the infected abdomen.

Authors:  Kristin C Turza; Chris A Campbell; Laura H Rosenberger; Amani D Politano; Stephen W Davies; Lin M Riccio; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2012-12-10       Impact factor: 2.150

Review 10.  Biologic versus nonbiologic mesh in ventral hernia repair: a systematic review and meta-analysis.

Authors:  Ali Darehzereshki; Melanie Goldfarb; Joerg Zehetner; Ashkan Moazzez; John C Lipham; Rodney J Mason; Namir Katkhouda
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.